Geng Li

Title: Geng Li - Innovator in Pharmaceutical Compositions

Introduction

Geng Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that target specific receptors in the human body. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Geng Li holds a patent for "Pharmaceutical compositions comprising anti-human TSLP receptor antibodies and methods of using the same." This patent details pharmaceutical compositions that include an anti-TSLP-R antibody or an antigen-binding fragment, along with a pharmaceutically acceptable buffer, excipient, and surfactant. The innovative nature of this patent lies in its potential applications in treating various conditions by targeting the TSLP receptor.

Career Highlights

Geng Li is currently associated with Upstream Bio, Inc., where he continues to push the boundaries of pharmaceutical research. His work at the company focuses on developing cutting-edge therapies that leverage his expertise in antibody technology. With a patent portfolio that includes 1 patent, he is recognized for his contributions to the field.

Collaborations

Geng Li collaborates with talented professionals in his field, including Parika Petaipimol and Robert Patrick Gearing. These collaborations enhance the research environment and foster innovation within the company.

Conclusion

Geng Li is a dedicated inventor whose work in pharmaceutical compositions is paving the way for new therapeutic options. His innovative approach and collaboration with skilled colleagues underscore his commitment to advancing healthcare solutions.